Abstract
Patient preferences for branded and generic drugs have been the subject of extensive research; however, few studies focused on patients suffering from severe illnesses like coronary heart disease (CHD). We did not find studies that measured the preference weights of different classes’ brands using the discrete choice experiment methodology.
Full Text
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call